Aspire BioPharma (ASBP)

Profile

Full Name

Aspire Biopharma Holdings, Inc.

Ticker Symbol

ASBP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 11, 2022

Indexes

Not included

Website

http://aspirebiolabs.com

Employees

2

Key Details

Price

$0.59(+11.32%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.01(+40.00% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.59
ASBP price is $0.59

30-Day Relative Volume

0.46
ASBP 30-day relative volume is 0.46

Price Performance

Price Most recent change

+11.32%
ASBP price was up +11.32% on Apr 11, 2025

Price YTD change

-94.87%
ASBP price is down -94.87% since January 1st

Price 1-year change

-94.69%
ASBP price is down -94.69% year-on-year

Price 3-year change

-94.09%
ASBP price is down -94.09% over the past 3 years

Price Range

Price All-time high

$15.80
ASBP price is currently -96.27% below its historical high of $15.80

Price 3-year low

$0.40
ASBP price is currently +47.13% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$27.14M
ASBP market capitalization is $27.14 million

Market cap 3-year change

-
ASBP market capitalization 3-year change is unknown

Market cap All-time high

$283.41M
ASBP market capitalization is currently -90.42% below its historical high of $283.41 million

Market cap sector rank

30.81%
ASBP market capitalization is higher than 30.81% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
ASBP shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
ASBP shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.56
ASBP beta is 1.56

200-day SMA

$9.54
ASBP price is currently -93.82% below its 200-day simple moving average

50-day SMA

$3.65
ASBP price is currently -83.84% below its 50-day simple moving average

RSI

27.56
ASBP 14-day relative strength index is 27.56

Volume

0.46
ASBP 30-day relative volume is 0.46

ATR

$0.15
ASBP average true range is $0.15

10-day Historical Volatility

175.98%
ASBP 10-day historical volatility is 175.98%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ASBP annual revenue value is unknown

Revenue Analysts estimate

-
ASBP annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ASBP annual revenue 1-year change is unknown

Revenue Sector rank

-
ASBP annual revenue is unknown

EPS

EPS

-$0.01
ASBP annual earnings per share is -$0.01

EPS Analysts estimate

-
ASBP annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+40%
ASBP annual earnings per share is up +40% year-on-year

EPS Sector rank

-
ASBP annual earnings per share is unknown

Profit

Gross profit

$0.00
ASBP annual gross profit is $0.00

Gross margin

-
ASBP annual gross profit margin value is unknown

Operating profit

-$358.60K
ASBP annual operating income is -$358.60 thousand

Operating margin

-
ASBP annual operating profit margin value is unknown

Net income

-$359.10K
ASBP annual net profit is -$359.10 thousand

Net margin

-
ASBP annual net profit margin value is unknown

Expenses

Total expenses

$358.60K
ASBP annual total expenses is $358.60 thousand

Operating expenses

$358.60K
ASBP annual total operating expenses is $358.60 thousand

Cost of goods sold

-
ASBP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$286.50K
ASBP annual SGA is $286.50 thousand

Depreciation and amortization

$0.00
ASBP annual depreciation & amortization is $0.00

Interest expense

$0.00
ASBP annual interest expense is $0.00

Income tax

$500.00
ASBP annual income tax is $500.00

EBIT & EBITDA

EBIT

-$358.60K
ASBP annual earnings before interest & taxes is -$358.60 thousand

EBITDA

-$358.60K
ASBP annual EBITDA is -$358.60 thousand

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$46.20K
ASBP annual total assets is $46.20 thousand

Non current assets

$0.00
ASBP annual long term assets is $0.00

Current assets

$46.20K
ASBP annual total current assets is $46.20 thousand

Cash and cash equivalents

$11.20K
ASBP annual cash & cash equivalents is $11.20 thousand

Accounts receivable

-
ASBP annual accounts receivable value is unknown

Inventory

-
ASBP annual inventory value is unknown

Liabilities

Total liabilities

$534.00K
ASBP annual total liabilities is $534.00 thousand

Long term liabilities

$0.00
ASBP annual total long term liabilities is $0.00

Current liabilities

$534.00K
ASBP annual total current liabilities is $534.00 thousand

Accounts payable

$172.80K
ASBP annual accounts payable is $172.80 thousand

Debt

Total debt

$360.60K
ASBP annual total debt is $360.60 thousand

Total debt 1-year change

+1187.86%
ASBP annual total debt is up +1187.86% year-on-year

Long term debt

-
ASBP annual long term debt value is unknown

Short term debt

$360.60K
ASBP annual short term debt is $360.60 thousand

Equity & Capital

Shareholders equity

-$487.90K
ASBP annual stockholders equity is -$487.90 thousand

Book value

-$487.90K
ASBP annual book value is -$487.90 thousand

Retained earnings

-$1.47M
ASBP annual retained earnings is -$1.47 million

Working capital

-$487.80K
ASBP annual working capital is -$487.80 thousand

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$87.00K
ASBP annual cash flow from operations is $87.00 thousand

Cash from operations 1-year change

+160.88%
ASBP annual cash flow from operations is up +160.88% year-on-year

Cash from investing

-$75.90K
ASBP annual cash flow from investing activities is -$75.90 thousand

Cash from investing 1-year change

+98.45%
ASBP annual cash flow from investing activities is up +98.45% year-on-year

Cash from financing

$0.00
ASBP annual cash flow from financing activities is $0.00

Cash from financing 1-year change

-100%
ASBP annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

-
ASBP annual capital expenditures value is unknown

CAPEX 1-year change

-
ASBP annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

$11.10K
ASBP annual free cash flow is $11.10 thousand

Free cash flow 1-year change

+100.22%
ASBP annual free cash flow is up +100.22% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ASBP annual gross profit margin value is unknown

Operating margin

-
ASBP annual operating profit margin value is unknown

Net margin

-
ASBP annual net profit margin value is unknown

ROA & ROE

ROA

-777.27%
ASBP annual return on assets is -777.27%

ROE

73.60%
ASBP annual return on equity is 73.60%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ASBP price to earnings ratio value is unknown

PE ratio Sector rank

-
ASBP price to earnings ratio is unknown

PB Ratio

PB ratio

-33.86
ASBP price to book ratio is -33.86

PB ratio Sector rank

0.9%
ASBP price to book ratio is higher than 0.9% of companies in Healthcare sector

PS Ratio

PS ratio

-
ASBP price to sales ratio value is unknown

PS ratio Sector rank

-
ASBP price to sales ratio is unknown

Enterprise value

Enterprise value

$27.98M
ASBP enterprise value is $27.98 million

Enterprise value Sector rank

35.61%
ASBP enterprise value is higher than 35.61% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-67.29
ASBP EV/EBITDA is -67.29

EV/EBITDA Sector rank

1.82%
ASBP EV/EBITDA is higher than 1.82% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.09
ASBP annual current ratio is 0.09

Quick ratio

-
ASBP annual quick ratio value is unknown

Leverage

Debt to equity

-0.74
ASBP annual debt to equity ratio is -0.74

Interest coverage ratio

-
ASBP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ASBP piotroski f-score value is unknown

Altman Z-Score

-
ASBP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

Grace Therapeutics (GRCE)
COCH logo
Envoy Medical (COCH)
BOLD logo
Boundless Bio (BOLD)
OS Therapies Incorporated (OSTX)
PLUR logo
Pluri (PLUR)
AKTX logo
Akari Therapeutics (AKTX)
CLGN logo
CollPlant Biotechnologies (CLGN)
FGEN logo
FibroGen (FGEN)
ALXO logo
ALX Oncology Holdings (ALXO)
  • What is the ticker symbol for Aspire BioPharma?
  • Does Aspire BioPharma pay dividends?
  • What sector is Aspire BioPharma in?
  • What industry is Aspire BioPharma in?
  • What country is Aspire BioPharma based in?
  • When did Aspire BioPharma go public?
  • Is Aspire BioPharma in the S&P 500?
  • Is Aspire BioPharma in the NASDAQ 100?
  • Is Aspire BioPharma in the Dow Jones?
  • When was Aspire BioPharma's last earnings report?
  • When does Aspire BioPharma report earnings?

What is the ticker symbol for Aspire BioPharma?

The ticker symbol for Aspire BioPharma is NASDAQ:ASBP

Does Aspire BioPharma pay dividends?

No, Aspire BioPharma does not pay dividends

What sector is Aspire BioPharma in?

Aspire BioPharma is in the Healthcare sector

What industry is Aspire BioPharma in?

Aspire BioPharma is in the Biotechnology industry

What country is Aspire BioPharma based in?

Aspire BioPharma is headquartered in United States

When did Aspire BioPharma go public?

Aspire BioPharma's initial public offering (IPO) was on April 11, 2022

Is Aspire BioPharma in the S&P 500?

No, Aspire BioPharma is not included in the S&P 500 index

Is Aspire BioPharma in the NASDAQ 100?

No, Aspire BioPharma is not included in the NASDAQ 100 index

Is Aspire BioPharma in the Dow Jones?

No, Aspire BioPharma is not included in the Dow Jones index

When was Aspire BioPharma's last earnings report?

Aspire BioPharma's most recent earnings report was on Apr 11, 2025

When does Aspire BioPharma report earnings?

The next expected earnings date for Aspire BioPharma is May 30, 2025
On this page